Last reviewed · How we verify
NCT03855800
Molecular Detection of Advanced Neoplasia in Pancreatic Cysts
NA trial testing Blood, stool, pancreatic juice and cyst fluid collection in Pancreas Cyst in 800 participants. Currently enrolling.
30 December 2030
Quick facts
| Lead sponsor | Mayo Clinic |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 800 |
| Start date | 11 May 2018 |
| Primary completion | 30 December 2030 |
| Estimated completion | 30 December 2030 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Blood, stool, pancreatic juice and cyst fluid collection
- Pancreatic Surgery
- Endoscopy Exam
Conditions studied
- Pancreas Cyst — all drugs for Pancreas Cyst →
Sponsor
Mayo Clinic
Who can join
Adults 18 to 120, any sex, with Pancreas Cyst. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers are trying to find out whether new tests ("biomarkers") of blood, stool, pancreas cyst fluid, or pancreas juice can be used to diagnose malignant or pre-malignant changes in pancreas cysts.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promising circulating biomarkers.
Mottini C, Auciello FR, Manni I, Pilarsky C, et al · · 2024 · cited 6× · PMID 39020414 · DOI 10.1186/s13046-024-03117-5
Verify or expand the search:
- PubMed search for NCT03855800
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pancreas Cyst
Currently open trials in the same condition.
- NCT05714111 — Radiology Registry on Pancreatic Malignancies · recruiting
- NCT05155878 — Prognostic Factors in Periampullary Tumors and Cysts · recruiting
- NCT04970056 — Pancreatic Cancer Early Detection Consortium · recruiting
- NCT03536793 — Tumour Regulatory Molecules in Early Pancreatic Cancer Detection · recruiting
- NCT06055010 — Improving Pancreatic Cancer Care by the Use of Computational Science and Technology · recruiting
Other Mayo Clinic trials
Trials by the same sponsor.
- NCT07126548 — A Point of Prostate Cancer Diagnosis Virtual Reality Assistant Intervention in Supporting Newly Diagnosed Black Men · NA · not yet recruiting
- NCT07221656 — Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration · not yet recruiting
- NCT06891001 — The Utilization of a Shoe Insert on Individuals With Unilateral Greater Trochanteric Pain Syndrome on Single Leg Stance, · NA · not yet recruiting
- NCT07169799 — Impact of Cryotherapy Spray (Tru-Freeze) for the Eradication of Gastric Antral Vascular Ectasia (ICE-GAVE) · NA · recruiting
- NCT07086183 — Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03855800 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mayo Clinic
- Last refreshed: 17 December 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03855800.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing